474 related articles for article (PubMed ID: 18661186)
1. Postoperative radiotherapy for stage IIIA rectal cancer: is it justified?
Kariv Y; Kariv R; Hammel JP; Lavery IC
Dis Colon Rectum; 2008 Oct; 51(10):1459-66. PubMed ID: 18661186
[TBL] [Abstract][Full Text] [Related]
2. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
Law WL; Ho JW; Chan R; Au G; Chu KW
Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
[TBL] [Abstract][Full Text] [Related]
3. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
5. Recurrence after transanal excision of T1 rectal cancer: should we be concerned?
Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC
Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186
[TBL] [Abstract][Full Text] [Related]
6. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
7. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
Temple LK; Bacik J; Savatta SG; Gottesman L; Paty PB; Weiser MR; Guillem JG; Minsky BD; Kalman M; Thaler HT; Schrag D; Wong WD
Dis Colon Rectum; 2005 Jul; 48(7):1353-65. PubMed ID: 15868235
[TBL] [Abstract][Full Text] [Related]
8. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
9. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
10. Preoperative radiotherapy improves outcome in recurrent rectal cancer.
Vermaas M; Ferenschild FT; Nuyttens JJ; Marinelli AW; Wiggers T; van der Sijp JR; Verhoef C; Graveland WJ; Eggermont AM; de Wilt JH
Dis Colon Rectum; 2005 May; 48(5):918-28. PubMed ID: 15785886
[TBL] [Abstract][Full Text] [Related]
11. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
Greene FL; Stewart AK; Norton HJ
J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
[TBL] [Abstract][Full Text] [Related]
12. Transanal excision vs. major surgery for T1 rectal cancer.
Endreseth BH; Myrvold HE; Romundstad P; Hestvik UE; Bjerkeset T; Wibe A;
Dis Colon Rectum; 2005 Jul; 48(7):1380-8. PubMed ID: 15906120
[TBL] [Abstract][Full Text] [Related]
13. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
14. Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
Eriksen MT; Wibe A; Haffner J; Wiig JN;
Dis Colon Rectum; 2007 Feb; 50(2):156-67. PubMed ID: 17180256
[TBL] [Abstract][Full Text] [Related]
15. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.
Chang GJ; Rodriguez-Bigas MA; Eng C; Skibber JM
Cancer; 2009 Dec; 115(23):5432-40. PubMed ID: 19673001
[TBL] [Abstract][Full Text] [Related]
16. Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer.
Tarantino I; Hetzer FH; Warschkow R; Zünd M; Stein HJ; Zerz A
Br J Surg; 2008 Mar; 95(3):375-80. PubMed ID: 18278781
[TBL] [Abstract][Full Text] [Related]
17. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection?
Sato H; Maeda K; Maruta M; Masumori K; Koide Y
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S3-12. PubMed ID: 17106812
[TBL] [Abstract][Full Text] [Related]
18. Extended radical resection: the choice for locally recurrent rectal cancer.
Heriot AG; Byrne CM; Lee P; Dobbs B; Tilney H; Solomon MJ; Mackay J; Frizelle F
Dis Colon Rectum; 2008 Mar; 51(3):284-91. PubMed ID: 18204879
[TBL] [Abstract][Full Text] [Related]
19. Outcome of transanal endoscopic microsurgery and adjuvant radiotherapy in patients with T2 rectal cancer.
Duek SD; Issa N; Hershko DD; Krausz MM
Dis Colon Rectum; 2008 Apr; 51(4):379-84; discussion 384. PubMed ID: 18236108
[TBL] [Abstract][Full Text] [Related]
20. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
